Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
- Heizmann M Center of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Switzerland.
- Itin P
- Wernli M
- Borradori L
- Bargetzi MJ
- 2001-06-26
Published in:
- American journal of hematology. - 2001
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma
Lymphoma, Follicular
Paraneoplastic Syndromes
Pemphigus
Rituximab
English
Paraneoplastic pemphigus is a severe mucocutaneous disease associated in most cases with B-cell lymphoproliferative disorders. Independent of the course of the underlying malignancy, this autoimmune skin disease is resistant to any treatment in most cases and may lead to death by infectious complications. We observed a patient with recovery of paraneoplastic pemphigus associated with follicular non-Hodgkin's-lymphoma after therapy with rituximab. In addition, we reviewed the literature and analyzed the few cases with comparable outcome with other treatment modalities.
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0
- PMID 11421295
- Persistent URL
- https://folia.unifr.ch/global/documents/13368
Statistics
Document views: 19
File downloads:
- fulltext.pdf: 0